Many epidemiological studies have shown up the frequent association of ar terial hypertension (HT) with atherosclerosis of different localizations. How ever, many of the drugs used to treat HT are contraindicated in patients with peripheral vascular disease (PVD), because they cause unfavorable metabolic changes or vasoconstriction. The aim of the present study was to assess the effect of a proven hypotensive drug, captopril, on the peripheral circulation. The drug appeared to be effec tive in improving blood flow to lower limbs, prolonging the pain. Free interval and increasing the angle/arm arteral pressure index
Subjects with peripheral arterial disease (PAD) of the lower limbs are at high risk for cardiovascul...
A vascular renin-angiotensin system (RAS) is present in the forearm vasculature of essential hyperte...
In order to clarify the mechanism of the hypotensive action of captopril, the acute and chronic effe...
Systemic and regional hemodynamics and cardiac structural changes were studied in 12 patients with m...
The increased total peripheral resistance that characterizes essential hypertension is generally rev...
The risk of peripheral artery disease is underestimated by many physicians; such risk is further aug...
The aim of the present investigation was to study the efficacy of captopril in a large group of hype...
This investigation was performed in two groups of adult patients, 10 with type I and 10 with type II...
Captopril, an orally active inhibitor of angiotensin converting enzyme, was administered for 12 mont...
Captopril, an orally active inhibitor of angiotensin converting enzyme, was administered for 12 mont...
The purpose of this investigation was to assess the effect of captopril on both systemic (P(a)) and ...
This randomized, double-blind, crossover study was aimed at detecting efficacy differences in blood ...
Peripheral arterial disease (PAD) of the lower limbs is the third most important site of atheroscler...
1. The effect of acute inhibition of angiotensin-converting enzyme by captopril (50 mg) on renal hae...
Angiotensin-converting enzyme (ACE) inhibitors are a new class of drugs, whose main indications are ...
Subjects with peripheral arterial disease (PAD) of the lower limbs are at high risk for cardiovascul...
A vascular renin-angiotensin system (RAS) is present in the forearm vasculature of essential hyperte...
In order to clarify the mechanism of the hypotensive action of captopril, the acute and chronic effe...
Systemic and regional hemodynamics and cardiac structural changes were studied in 12 patients with m...
The increased total peripheral resistance that characterizes essential hypertension is generally rev...
The risk of peripheral artery disease is underestimated by many physicians; such risk is further aug...
The aim of the present investigation was to study the efficacy of captopril in a large group of hype...
This investigation was performed in two groups of adult patients, 10 with type I and 10 with type II...
Captopril, an orally active inhibitor of angiotensin converting enzyme, was administered for 12 mont...
Captopril, an orally active inhibitor of angiotensin converting enzyme, was administered for 12 mont...
The purpose of this investigation was to assess the effect of captopril on both systemic (P(a)) and ...
This randomized, double-blind, crossover study was aimed at detecting efficacy differences in blood ...
Peripheral arterial disease (PAD) of the lower limbs is the third most important site of atheroscler...
1. The effect of acute inhibition of angiotensin-converting enzyme by captopril (50 mg) on renal hae...
Angiotensin-converting enzyme (ACE) inhibitors are a new class of drugs, whose main indications are ...
Subjects with peripheral arterial disease (PAD) of the lower limbs are at high risk for cardiovascul...
A vascular renin-angiotensin system (RAS) is present in the forearm vasculature of essential hyperte...
In order to clarify the mechanism of the hypotensive action of captopril, the acute and chronic effe...